Verrica Pharmaceuticals (VRCA)
(Delayed Data from NSDQ)
$8.18 USD
-0.60 (-6.83%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $8.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 29.63% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.57 |
Next Year | -0.83 |
EPS (TTM) | -1.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.70M | 7.62M | 25.92M | 81.33M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 5.14M | 7.94M | 28.13M | 95.00M |
Low Estimate | 4.00M | 7.11M | 24.50M | 64.24M |
Year ago Sales | 0.18M | 2.92M | 5.12M | 25.92M |
Year over Year Growth Est. | 2,511.11% | 160.82% | 405.91% | 213.72% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.37 | -1.57 | -0.83 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.47 | -0.33 | -1.49 | -0.57 |
High Estimate | -0.40 | -0.33 | -1.49 | -0.57 |
Low Estimate | -0.47 | -0.39 | -1.60 | -1.27 |
Year ago EPS | -0.21 | -0.32 | -1.14 | -1.57 |
Year over Year Growth Est. | -104.76% | -15.63% | -37.72% | 46.97% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 3 | 2 |
Down Last 60 Days | 1 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.37 | -1.57 | -0.83 |
7 Days Ago | -0.43 | -0.37 | -1.57 | -0.83 |
30 Days Ago | -0.47 | -0.39 | -1.59 | -0.63 |
60 Days Ago | -0.47 | -0.39 | -1.59 | -0.63 |
90 Days Ago | -0.47 | -0.39 | -1.59 | -0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.43 | -0.37 | -1.57 | -0.83 |
Zacks Consensus Estimate | -0.43 | -0.37 | -1.57 | -0.83 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.48 | -0.32 | -0.21 | NA |
Estimate | -0.54 | -0.47 | -0.22 | -0.22 | NA |
Difference | 0.16 | -0.01 | -0.10 | 0.01 | 0.02 |
Surprise | 29.63% | -2.13% | -45.45% | 4.55% | -3.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more